Analysed CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS) News Sources
ConvaTec Group Product Pipeline Analysis Report 2025 | Emphasizing Innovation in Therapies for Chronic Conditions and Exploiting Market-entry, R&D, and In/Out-licensing Strategies
05-01-2026
yahoo.com
UK Value Stocks: Fevertree Drinks Among 3 Selections Possibly Trading Below Fair Value
12-01-2026
yahoo.com
Why The Narrative Around Convatec Group LSE CTEC Is Shifting After Fresh Analyst And Holder Moves
09-02-2026
yahoo.com
$3.8 Billion Negative Pressure Wound Therapy (NPWT) Devices Market Assessment, 2030 - Featuring Solventum, Smith+Nephew, Cardinal Health, Molnlycke Health Care, ConvaTec Group and Other Key Players
19-02-2026
yahoo.com
Ostomy Dressing Market Forecasts Growth from $3.80B (2026) to $4.73B by 2031, Profiling Coloplast, ConvaTec, Hollister, B. Braun & Salts Healthcare
24-09-2026
yahoo.com
Convatec Expands Cure™ Portfolio With Launch of Cure Aqua™, Bringing Greater Choice to People Who Catheterize
28-09-2026
yahoo.com
What is the current price of CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS)?
The current price of CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS) is $11.81.
CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS) since the previous trading day is $0.35.
CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS) since the previous trading day is 3.0541%.
What is the most recent average sentiment score for CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS)?
The most recent average sentiment score for CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS) is 71 out of 100.
What is the most recent average sentiment for CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS)?
The most recent sentiment for CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS) is .
SEC-8K** Filing Available For CONVATEC GROUP PLC-UNSP ADR (CNVVY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.